Serena Williams has been diagnosed with pulmonary embolism and deep vein thrombosis, serious blood clot conditions that have led to multiple medical emergencies. These diagnoses have shaped her health journey, particularly during and after pregnancy, and required aggressive treatment and long-term management.
The 2011 pulmonary embolism
In 2011, Serena Williams developed a pulmonary embolism after cutting her foot on broken glass and undergoing surgery. The injury and reduced mobility likely contributed to a blood clot forming in her leg, which then traveled to her lungs. This bilateral pulmonary embolism caused severe breathing difficulties and required immediate treatment with anticoagulants.
The event revealed a vulnerability to venous thromboembolism, a condition where blood clots form in deep veins and can move to the lungs. Despite her elite fitness, the combination of surgery, travel, and immobility created a high-risk scenario. This episode marked the beginning of her ongoing battle with clotting disorders.
Deep vein thrombosis as a recurring risk
Deep vein thrombosis (DVT) has been a consistent threat for Williams. DVT occurs when a clot forms in deep veins, usually in the legs, and can lead to pulmonary embolism if the clot breaks loose. After her 2011 diagnosis, her risk of recurrence increased significantly, especially during periods of reduced activity or medical stress.
Her awareness of DVT symptoms—such as leg swelling and shortness of breath—has been critical. This knowledge likely saved her life during her postpartum recovery, when she recognized the signs of another clot early. Athletes, especially those who travel frequently, face elevated DVT risks due to prolonged sitting and dehydration.
The 2017 postpartum emergency
After delivering her daughter via emergency C-section in 2017, Williams experienced shortness of breath and suspected another pulmonary embolism. She requested a CT scan and heparin, but her concerns were initially dismissed by medical staff. This delay highlights a broader issue in maternal healthcare, particularly for Black women, who face higher rates of complications and mortality.
When the scan confirmed blood clots in her lungs, she was started on blood thinners. However, the anticoagulants caused her C-section incision to reopen and led to a large abdominal hematoma. This complication required emergency intervention and a shift in treatment strategy.
Treatment and long-term management
To prevent further clots while managing bleeding risk, doctors inserted an inferior vena cava (IVC) filter. This device catches clots before they reach the lungs and is often used when anticoagulants are too dangerous. While effective, IVC filters carry risks, including migration or vein damage, and are typically used as a temporary measure.
Williams’ case underscores the complexity of treating clotting disorders in high-risk patients. Balancing the need to prevent life-threatening clots with the danger of uncontrolled bleeding requires careful, individualized care. Her experience has brought attention to the importance of patient advocacy, especially for women of color in healthcare settings.
